Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 15,740 shares at $59.91 ($935K) on 2021-05-03, disclosed to the SEC on 2021-05-05.
Open-market sale of $935k ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.12 | 1,100 | $63K | 6.7% |
| 2 | $58.09 | 1,630 | $95K | 10.1% |
| 3 | $58.09 | 1,630 | $95K | 10.1% |
| 4 | $59.91 | 4,567 | $274K | 29.3% |
| 5 | $59.91 | 4,567 | $274K | 29.3% |
| 6 | $60.23 | 1,123 |
| $68K |
| 7.2% |
| 7 | $60.23 | 1,123 | $68K | 7.2% |
| Total | $59.38 avg | 15,740 | $935K | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |